Claybrook Capital LLC bought a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 245 shares of the medical equipment provider’s stock, valued at approximately $51,000.

Other institutional investors have also recently modified their holdings of the company. Courier Capital LLC grew its position in shares of Align Technology by 0.9% in the 4th quarter. Courier Capital LLC now owns 5,605 shares of the medical equipment provider’s stock worth $1,174,000 after buying an additional 50 shares during the last quarter. Captrust Financial Advisors grew its position in shares of Align Technology by 67.6% in the 4th quarter. Captrust Financial Advisors now owns 124 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 50 shares during the last quarter. Gemmer Asset Management LLC grew its position in shares of Align Technology by 57.3% in the 4th quarter. Gemmer Asset Management LLC now owns 140 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 51 shares during the last quarter. Wedbush Securities Inc. grew its position in shares of Align Technology by 6.6% in the 4th quarter. Wedbush Securities Inc. now owns 968 shares of the medical equipment provider’s stock worth $203,000 after buying an additional 60 shares during the last quarter. Finally, ETF Managers Group LLC grew its position in shares of Align Technology by 15.5% in the 4th quarter. ETF Managers Group LLC now owns 513 shares of the medical equipment provider’s stock worth $107,000 after buying an additional 69 shares during the last quarter. 81.86% of the stock is currently owned by hedge funds and other institutional investors.

ALGN stock opened at $252.33 on Friday. The company has a market capitalization of $20.18 billion, a P/E ratio of 51.29, a P/E/G ratio of 2.29 and a beta of 2.12. Align Technology, Inc. has a 52 week low of $177.93 and a 52 week high of $398.88.

Align Technology (NASDAQ:ALGN) last released its earnings results on Tuesday, January 29th. The medical equipment provider reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.04. The company had revenue of $534.02 million during the quarter, compared to analysts’ expectations of $512.03 million. Align Technology had a net margin of 20.35% and a return on equity of 33.41%. Analysts anticipate that Align Technology, Inc. will post 5.08 earnings per share for the current fiscal year.

In other Align Technology news, Director Joseph Lacob sold 20,000 shares of Align Technology stock in a transaction that occurred on Thursday, February 28th. The shares were sold at an average price of $258.31, for a total transaction of $5,166,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Yuval Shaked sold 400 shares of Align Technology stock in a transaction that occurred on Monday, February 25th. The shares were sold at an average price of $255.52, for a total transaction of $102,208.00. Following the sale, the director now owns 24 shares of the company’s stock, valued at $6,132.48. The disclosure for this sale can be found here. Insiders sold a total of 21,650 shares of company stock valued at $5,586,633 over the last quarter. 1.40% of the stock is owned by company insiders.

A number of brokerages have recently issued reports on ALGN. ValuEngine raised shares of Align Technology from a “hold” rating to a “buy” rating in a research report on Friday, March 1st. Robert W. Baird lifted their price objective on shares of Align Technology from $255.00 to $286.00 and gave the stock an “outperform” rating in a research report on Tuesday, March 5th. They noted that the move was a valuation call. UBS Group downgraded shares of Align Technology from a “buy” rating to a “neutral” rating and set a $275.00 price objective on the stock. in a research report on Thursday, February 14th. OTR Global downgraded shares of Align Technology to a “positive” rating in a research report on Thursday. Finally, William Blair reaffirmed an “outperform” rating on shares of Align Technology in a research report on Monday, November 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $331.59.

WARNING: This article was reported by Marea Informative and is owned by of Marea Informative. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.mareainformativa.com/news/2019/03/17/claybrook-capital-llc-takes-51000-position-in-align-technology-inc-algn.html.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases.

See Also: How Do You Calculate Return on Equity (ROE)?

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.